PCOM2 - The Physician Communication Intervention, Version 2.0

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age9-17
SponsorUniversity of Colorado, Denver

About this trial

Poor quality of primary care providers' vaccine recommendations lead to low adolescent human papillomavirus vaccination rates and hundreds of thousands of adolescents unnecessarily at risk for HPV-associated cancers and diseases. Though a previous provider communication intervention, called PCOM, was found to be effective for increasing adolescent HPV vaccination in primary care, its dissemination is limited by the need for significant research team involvement to teach providers how to use the intervention's components. To address this, investigators propose to develop and test a virtual version of PCOM, use mixed methods to assess contextual factors affecting its use compared to the original PCOM intervention, and develop an optimized version of PCOM for broad dissemination to increase adolescent HPV vaccination nationally.

Eligibility criteria

Qualifiers

Parents: Have an adolescent between the ages of 9-17 years old and receiving adolescent care at an enrolled clinic

Providers: All providers at participating study practices will be eligible to participate.

Disqualifiers

Parents: Does not have an adolescent between the ages of 9-17 years old and is not receiving adolescent care at an enrolled clinic

Providers: Providers who are not at participating study practices

Trial design

Treatments tested in this trial

  • Physician Communication 2 Virtual (PCOM2-virtual)
  • Physician Communication Standard (PCOM-standard)

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Colorado, Denver

Lead sponsor

University of Kansas Medical Center

Collaborator

San Diego State University

Collaborator